Quantity and Quality: An Rx for Efficient Drug Purchasing

AEI Health Policy Outlook, No. 8, September 2008

9 Pages Posted: 23 Oct 2013

See all articles by Roger Bate

Roger Bate

American Enterprise Institute (AEI)

Karen Porter

American Enterprise Institute (AEI)

Date Written: September 18, 2008

Abstract

Drug procurement agencies and organizations spend billions of dollars on drugs for patients in the developing world. These drugs are essential to the health of many millions of patients — but only if they are safe and effective. The World Health Organization (WHO) and the Global Fund to Fight AIDS, Tuberculosis and Malaria offer "prequalification" programs designed to help drug procurers identify suppliers of safe and effective drugs. But while they do some good, both programs are flawed: they focus too little on drug quality, favor local producers that may not qualify under the more rigorous drug approval systems of the United States and Europe, and exercise little oversight of how drug procurers use their lists. Such bureaucratic bungling can mean the difference between life and death.

Suggested Citation

Bate, Roger and Porter, Karen, Quantity and Quality: An Rx for Efficient Drug Purchasing (September 18, 2008). AEI Health Policy Outlook, No. 8, September 2008, Available at SSRN: https://ssrn.com/abstract=2342850 or http://dx.doi.org/10.2139/ssrn.2342850

Roger Bate (Contact Author)

American Enterprise Institute (AEI) ( email )

1150 17th Street, N.W.
Washington, DC 20036
United States

Karen Porter

American Enterprise Institute (AEI) ( email )

1150 17th Street, N.W.
Washington, DC 20036
United States

Here is the Coronavirus
related research on SSRN

Paper statistics

Downloads
18
Abstract Views
208
PlumX Metrics